Late MitraClip procedure after left atrial appendage occlusion

We report the first human case of percutaneous edge‐to‐edge mitral valve repair using MitraClip System (Abbott Vascular, Abbott Park, IL) in a patient, who previously underwent left atrial appendage closure with PLAATO™ System (ev3. Inc., Plymouth, MN). The procedure was successfully performed using the standard MitraClip technique, in the catheterization laboratory, with transesophageal echocardiographic and fluoroscopic guidance. We showed that a double percutaneous procedure for stroke prevention and mitral regurgitation treatment might be a valid approach in selected patients ineligible for chronic anticoagulation therapy and at high risk for conventional cardiac surgery. © 2013 Wiley Periodicals, Inc.

[1]  Gerhard Hindricks,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[3]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[4]  T. Meinertz,et al.  MitraClip® therapy in patients with end‐stage systolic heart failure , 2011, European journal of heart failure.

[5]  J. Gorman,et al.  Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.

[6]  Jean-Louis Vanoverschelde,et al.  EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. , 2011, European heart journal.

[7]  Antonio Colombo,et al.  Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting , 2010, European heart journal.

[8]  M. Acker,et al.  Mitral valve surgery in advanced heart failure. , 2010, Journal of the American College of Cardiology.

[9]  P. Neužil,et al.  PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[11]  C. Tamburino,et al.  Percutaneous closure of left atrial appendage to prevent embolic events in high‐risk patients with chronic atrial fibrillation , 2009 .

[12]  Timothy Watson,et al.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.

[13]  Philippe Ravaud,et al.  What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? , 2007, European heart journal.

[14]  Bernhard Meier,et al.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. , 2005, Journal of the American College of Cardiology.